Study of a custom nicardipine syrup for children with cancer
Part of Heart & circulation clinical trials.
This study looks at how a custom-made nicardipine syrup works in children aged 1 to 15 who are being treated for blood cancers or solid tumors. The goal is to make sure the dose is right for each child.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 15 years old.
- You are being treated for a childhood blood cancer or solid tumor.
- You have a special IV line (called a central line) for blood draws.
- You need a liquid form of nicardipine that is not available as a store-bought medicine.
- You take nicardipine every 8 hours.
- You have health insurance (social security).
- Your parents or guardians agree to the study, and you do not object.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial helps children, teens, and young adults get an innovative cancer medicine when their disease has returned or hasn’t responded—and standard options are not available. It checks whether a “compassionate use” or off-label medicine plan can be carried out safely for the people who need it.
This trial tests how safe regadenoson is in children and how the body handles it after dosing. It also uses a heart “stress test” with MRI (CMR) when doctors feel it’s needed.
This trial measures how anti-infective medicines move through a child’s body while they are in the hospital or during follow-up. The goal is to better understand dosing and drug exposure in critically ill children.
This study asks children with cancer to share their experiences and symptoms while taking new, innovative medicines that are not yet standard. The goal is to learn how these treatments affect daily life, so doctors can better support children and families during treatment.
This study measures how children’s bodies handle medicines they are already prescribed as standard care. It may help doctors choose safer, more accurate doses for children in the future.
This study measures how certain medicines move through the body and checks their safety in children. It may help doctors better understand dosing and side effects in kids who are already receiving these treatments, or in some kids who recently tested positive for COVID-19.
Hear when a new Hypertensive Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.